Chester County News and Community Website
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) and Pediatrix Therapeutics, Inc. this week announced that the companies have entered into a license agreement. Under the license agreement, Aclaris has …
Aclaris Therapeutics and Pediatrix Therapeutics Announce License Agreement for ATI-1777 in Greater China Read More
KING OF PRUSSIA, PA —CSL Limited (ASX: CSL; USOTC: CSLLY) announced that its subsidiary, CSL Seqirus, recently entered into a collaboration and license agreement with Arcturus Therapeutics Holdings Inc (“Arcturus …
CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced it recently entered into a global licensing agreement with Lee’s Pharmaceutical (HK) Limited, (Lee’s) and its affiliate Zhaoke Pharmaceutical (Hefei) Co. …
Windtree Therapeutics Announces KL4 Surfactant and AEROSURF Global License Agreement Read More
WILMINGTON, DE — InterDigital, Inc. (NASDAQ: IDCC) announced that it recently signed a multi-year, worldwide, non-exclusive, royalty-bearing license with Zebra Technologies Corporation under InterDigital’s standard-essential patents related to 4G and …
InterDigital Signs License Agreement with Zebra Technologies Corporation Read More
HARRISBURG, PA — Rep. Todd Polinchock (R-Bucks) recently introduced legislation to amend the Real Estate Licensing and Registration Act (RELRA), Act 9 of 1980, to permit real estate schools which …
Polinchock Introduces Legislation to Allow Remote Learning for Real Estate Schools Read More
WEST CHESTER, PA — AAA has expanded retail services at its West Chester Car Care, Insurance and Travel Center to offer convenience and peace of mind to AAA Members and …
AAA Now Offers State Agency Identification Services in West Chester Read More
HARRISBURG, PA — The Pennsylvania Department of State announced that its professional licensing waivers issued under the COVID-19 disaster declaration will begin to expire in several phases starting August 17.
Commonwealth to End Pandemic-Related Licensing Waivers Read More
EXTON, PA — Melior Pharmaceuticals announced that it completed a definitive licensing agreement with Adhera Therapeutics, Inc . (OTCPK: ATRX) for Melior’s Parkinson’s disease (PD) candidate, MLR-1019 (armesocarb).
Melior Pharmaceuticals Announces Execution of License Agreement for Armesocarb by Adhera Therapeutics Read More